Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 16562.09 | 459 / 459 | 100% | 95.73 | 1118 / 1118 |
esophagus | 100% | 10909.66 | 1445 / 1445 | 100% | 88.73 | 183 / 183 |
intestine | 100% | 13090.51 | 966 / 966 | 100% | 82.35 | 527 / 527 |
liver | 100% | 7217.92 | 226 / 226 | 100% | 81.60 | 406 / 406 |
lung | 100% | 11380.93 | 578 / 578 | 100% | 70.59 | 1155 / 1155 |
ovary | 100% | 10777.63 | 180 / 180 | 100% | 80.34 | 430 / 430 |
stomach | 100% | 9132.54 | 359 / 359 | 100% | 87.50 | 286 / 286 |
prostate | 100% | 8179.52 | 245 / 245 | 100% | 54.99 | 501 / 502 |
uterus | 100% | 8985.01 | 170 / 170 | 100% | 69.26 | 458 / 459 |
kidney | 100% | 11026.58 | 89 / 89 | 100% | 100.60 | 899 / 901 |
thymus | 100% | 7526.74 | 652 / 653 | 100% | 74.53 | 604 / 605 |
bladder | 100% | 13146.95 | 21 / 21 | 100% | 68.70 | 502 / 504 |
brain | 99% | 5815.84 | 2625 / 2642 | 100% | 77.32 | 705 / 705 |
skin | 100% | 10235.71 | 1809 / 1809 | 99% | 62.66 | 467 / 472 |
pancreas | 99% | 6120.85 | 324 / 328 | 100% | 64.53 | 178 / 178 |
adrenal gland | 100% | 9761.68 | 258 / 258 | 97% | 45.84 | 222 / 230 |
adipose | 100% | 18503.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 9998.76 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 80.16 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 61.72 | 29 / 29 |
muscle | 100% | 13356.13 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 8653.77 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 67.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 35.60 | 1 / 1 |
peripheral blood | 100% | 7909.42 | 927 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 8395.74 | 847 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007613 | Biological process | memory |
GO_0006412 | Biological process | translation |
GO_0031929 | Biological process | TOR signaling |
GO_0048167 | Biological process | regulation of synaptic plasticity |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0035176 | Biological process | social behavior |
GO_0045947 | Biological process | negative regulation of translational initiation |
GO_0098794 | Cellular component | postsynapse |
GO_0043232 | Cellular component | intracellular non-membrane-bounded organelle |
GO_0071598 | Cellular component | neuronal ribonucleoprotein granule |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0030371 | Molecular function | translation repressor activity |
GO_0005515 | Molecular function | protein binding |
GO_0008190 | Molecular function | eukaryotic initiation factor 4E binding |
Gene name | EIF4EBP2 |
Protein name | eIF4EBP2 protein Eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2) (eIF4E-binding protein 2) |
Synonyms | |
Description | FUNCTION: Repressor of translation initiation involved in synaptic plasticity, learning and memory formation . Regulates EIF4E activity by preventing its assembly into the eIF4F complex: hypophosphorylated form of EIF4EBP2 competes with EIF4G1/EIF4G3 and strongly binds to EIF4E, leading to repress translation. In contrast, hyperphosphorylated form dissociates from EIF4E, allowing interaction between EIF4G1/EIF4G3 and EIF4E, leading to initiation of translation . EIF4EBP2 is enriched in brain and acts as a regulator of synapse activity and neuronal stem cell renewal via its ability to repress translation initiation (By similarity). Mediates the regulation of protein translation by hormones, growth factors and other stimuli that signal through the MAP kinase and mTORC1 pathways (By similarity). . |
Accessions | Q13542 ENST00000373218.5 Q6FG68 |